800 related articles for article (PubMed ID: 33374253)
1. Myeloid Cells in Glioblastoma Microenvironment.
De Leo A; Ugolini A; Veglia F
Cells; 2020 Dec; 10(1):. PubMed ID: 33374253
[TBL] [Abstract][Full Text] [Related]
2. The Role of Myeloid Cells in GBM Immunosuppression.
Lin YJ; Wu CY; Wu JY; Lim M
Front Immunol; 2022; 13():887781. PubMed ID: 35711434
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts.
Yabo YA; Moreno-Sanchez PM; Pires-Afonso Y; Kaoma T; Nosirov B; Scafidi A; Ermini L; Lipsa A; Oudin A; Kyriakis D; Grzyb K; Poovathingal SK; Poli A; Muller A; Toth R; Klink B; Berchem G; Berthold C; Hertel F; Mittelbronn M; Heiland DH; Skupin A; Nazarov PV; Niclou SP; Michelucci A; Golebiewska A
Genome Med; 2024 Apr; 16(1):51. PubMed ID: 38566128
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic plasticity of myeloid cells in glioblastoma development, progression, and therapeutics.
Ye Z; Ai X; Zhao L; Fei F; Wang P; Zhou S
Oncogene; 2021 Oct; 40(42):6059-6070. PubMed ID: 34556813
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities.
Wang G; Zhong K; Wang Z; Zhang Z; Tang X; Tong A; Zhou L
Front Immunol; 2022; 13():964898. PubMed ID: 35967394
[TBL] [Abstract][Full Text] [Related]
6. Revealing and Harnessing Tumour-Associated Microglia/Macrophage Heterogeneity in Glioblastoma.
Pires-Afonso Y; Niclou SP; Michelucci A
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973030
[No Abstract] [Full Text] [Related]
7. Microglia-Centered Combinatorial Strategies Against Glioblastoma.
Martins TA; Schmassmann P; Shekarian T; Boulay JL; Ritz MF; Zanganeh S; Vom Berg J; Hutter G
Front Immunol; 2020; 11():571951. PubMed ID: 33117364
[TBL] [Abstract][Full Text] [Related]
8. Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study.
Ali S; Borin TF; Piranlioglu R; Ara R; Lebedyeva I; Angara K; Achyut BR; Arbab AS; Rashid MH
PLoS One; 2021; 16(2):e0246646. PubMed ID: 33544755
[TBL] [Abstract][Full Text] [Related]
9. Metabolic therapy: a new paradigm for managing malignant brain cancer.
Seyfried TN; Flores R; Poff AM; D'Agostino DP; Mukherjee P
Cancer Lett; 2015 Jan; 356(2 Pt A):289-300. PubMed ID: 25069036
[TBL] [Abstract][Full Text] [Related]
10. Macrophages and microglia: the cerberus of glioblastoma.
Buonfiglioli A; Hambardzumyan D
Acta Neuropathol Commun; 2021 Mar; 9(1):54. PubMed ID: 33766119
[TBL] [Abstract][Full Text] [Related]
11. Friends with Benefits: Chemokines, Glioblastoma-Associated Microglia/Macrophages, and Tumor Microenvironment.
Codrici E; Popescu ID; Tanase C; Enciu AM
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269652
[TBL] [Abstract][Full Text] [Related]
12. Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.
Poli A; Wang J; Domingues O; Planagumà J; Yan T; Rygh CB; Skaftnesmo KO; Thorsen F; McCormack E; Hentges F; Pedersen PH; Zimmer J; Enger PØ; Chekenya M
Oncotarget; 2013 Sep; 4(9):1527-46. PubMed ID: 24127551
[TBL] [Abstract][Full Text] [Related]
13. Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies.
Huang B; Zhang J; Zong W; Chen S; Zong Z; Zeng X; Zhang H
Front Immunol; 2023; 14():994698. PubMed ID: 36923402
[TBL] [Abstract][Full Text] [Related]
14. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.
Lin H; Liu C; Hu A; Zhang D; Yang H; Mao Y
J Hematol Oncol; 2024 May; 17(1):31. PubMed ID: 38720342
[TBL] [Abstract][Full Text] [Related]
15. Role of myeloid cells in the immunosuppressive microenvironment in gliomas.
Locarno CV; Simonelli M; Carenza C; Capucetti A; Stanzani E; Lorenzi E; Persico P; Della Bella S; Passoni L; Mavilio D; Bonecchi R; Locati M; Savino B
Immunobiology; 2020 Jan; 225(1):151853. PubMed ID: 31703822
[TBL] [Abstract][Full Text] [Related]
16. Macrophages/Microglia in the Glioblastoma Tumor Microenvironment.
Ma J; Chen CC; Li M
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071306
[TBL] [Abstract][Full Text] [Related]
17. Microglia in Cancer: For Good or for Bad?
da Fonseca AC; Amaral R; Garcia C; Geraldo LH; Matias D; Lima FR
Adv Exp Med Biol; 2016; 949():245-261. PubMed ID: 27714693
[TBL] [Abstract][Full Text] [Related]
18. Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma.
Arbab AS; Rashid MH; Angara K; Borin TF; Lin PC; Jain M; Achyut BR
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258180
[TBL] [Abstract][Full Text] [Related]
19. Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma.
Pang L; Khan F; Heimberger AB; Chen P
Trends Cancer; 2022 Oct; 8(10):839-854. PubMed ID: 35624002
[TBL] [Abstract][Full Text] [Related]
20. Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy.
Kamran N; Chandran M; Lowenstein PR; Castro MG
Clin Immunol; 2018 Apr; 189():34-42. PubMed ID: 27777083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
